SCHEMBL1753592

SCHEMBL1753592

CCC1CN(C)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13887656 1.00
SCHEMBL13887646 1.00
Hydrochloric Acid SCHEMBL28273479 0.98 HRH3 (0.39)
Bromide SCHEMBL18394892 0.98 HRH3 (0.39)
SCHEMBL27953404 0.92 HRH3 (0.37)
Thiocyanic Acid SCHEMBL26110665 0.89 HRH3 (0.35)
SCHEMBL16939080 0.87 PDK1 (0.37)
SCHEMBL13229791 0.87 PDK1 (0.37)
SCHEMBL18730601 0.84 ACKR3 (0.38)
SCHEMBL9936731 0.84 HRH3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109314273-A Zinc halide cell using deep eutectic solvent based electrolyte EOS能源储存有限责任公司 2019-02-05 CN claimed
CN-103534867-B Ionic liquid containing sulfonate ions 流体公司 2017-04-12 CN claimed
EP-4400497-A1 3CLPRO PROTEASE INHIBITOR Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) 2024-07-17 EP disclosed
US-20240228493-A1 LRRK2 INHIBITORS AND USES THEREOF NEURON23, INC. 2024-07-11 US disclosed
WO-2024141757-A1 LSD1 MODULATORS EXSCIENTIA AI LIMITED (GB) 2024-07-04 WO disclosed
WO-2024138206-A1 FLUOROPYRIDOPYRIMIDINE AND FLUOROQUINAZOLINE DERIVATIES AND METHODS OF USE THEREOF FRONTIER MEDICINES CORPORATION (US) 2024-06-27 WO disclosed
WO-2023205595-A2 EGFR INHIBITORS IN CANCER TREATMENT CELYN THERAPEUTICS, INC (US) 2023-10-26 WO disclosed
US-20230258569-A1 REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION FUJIFILM CORPORATION (JP) 2023-08-17 US disclosed
WO-2023150394-A1 METHODS FOR TREATMENT OF CANCER FRONTIER MEDICINES CORPORATION (US) 2023-08-10 WO disclosed
EP-4223751-A1 BENZAMIDE COMPOUND AND USE THEREOF Humanwell Healthcare (Group) Co., Ltd. (CN) 2023-08-09 EP disclosed
US-20230219986-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-07-13 US disclosed
US-7524852-B2 Bicyclic pyrimidine derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-04-28 US disclosed
WO-2008148074-A2 INHIBITORS OF MTOR AND METHODS OF TREATMENT USING SAME RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-12-04 WO disclosed
WO-2008049808-A1 MTP INHIBITING TETRAHYDRO-NAPHTHALENE-1-CARBOXYLIC ACID DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2008-05-02 WO disclosed
US-20070238727-A1 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals TIBOTEC BVBA (BE) 2007-10-11 US disclosed
US-20070238727-A1 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals TIBOTEC BVBA (BE) 2007-10-11 US disclosed
US-20070037834-A1 Anti-inflammatory; cellular infiltration inhibition modulating activity on thymus and activation-regulated chemokine and macrophage-derived chemokine functions; inhibitory activities against binding of TARC and MDC to T cells; allergic disease, autoimmune disease, transplant, graft rejection KYOWA HAKKO KIRIN CO., LTD. (JP) 2007-02-15 US disclosed
US-4992150-A Telomer with alpha-olefin;oil and fuel additive NIPPON OIL CO, LTD. (JP) 1991-02-12 US disclosed
US-4176218-A CO-CATALYST OF A TERTIARY AMINE AND A BASIC METAL SALT BASF WYANDOTTE CORPORATION (US) 1979-11-27 US disclosed
EP-0003210-A1 High resilience flexible foamed polyurethanes, foamable mixtures and process therefor BASF WYANDOTTE CORPORATION (US) 1979-08-08 EP disclosed